Capital Royalty L.P., a Houston-based trailblazer when it comes to investing in healthcare companies, has announced the closure of their second private equity fund. Capital Royalty Partners II was reported to have surpassed the Firm’s original fundraising target and is closing, oversubscribed, and with $805 million in equity commitments.
http://bionews-tx.com/news/2013/05/06/houston-texas-capital-royalty-announces-closure-of-second-private-equity-fund/
Showing posts with label Capital. Show all posts
Showing posts with label Capital. Show all posts
Tuesday, May 7, 2013
Monday, February 25, 2013
Texas Biotech Company to Present in New York City on Wednesday
This Wednesday, February 27, 2013, New York City will host the RBC Markets Capital Healthcare Conference. One of Texas’ own biotech companies will be a presenter, providing an overview of their clinical developments and milestones. Brian Zambrowicz, Ph.D. is the Executive Vice President and Chief Scientific Officer of the Texas-based company Lexicon Pharmaceuticals Inc., and will at the present at the upcoming conference.
http://www.swbiosearch.com/2013/02/25/texas-biotech-company-to-present-in-new-york-city-on-wednesday/
Subscribe to:
Posts (Atom)